Michael D.

Michael D. is a seasoned sales professional in the oncology and surgical sectors with extensive experience in launching and promoting pharmaceutical products. Currently serving as a Senior Oncology Sales Representative at Eisai US since April 2018, Michael D. achieved notable success by promoting the first-ever combination therapy for endometrial cancer and a first-line therapy for unresectable hepatocellular carcinoma. Prior to this role, Michael D. was a BioSurgery Business Manager at Mallinckrodt Pharmaceuticals and Sanofi Genzyme, where responsibilities included launching innovative surgical products. Additional experience includes founding and operating MWD Medical, LLC, which exclusively distributed Stryker products in Florida, and serving as a Primary Care Sales Representative at Daiichi Sankyo, Inc. Michael D. holds a Bachelor of Science in Business Administration and Management from Coastal Carolina University.